e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vanda Pharmaceuticals Inc. - Common Stock
(NQ:
VNDA
)
8.820
+1.790 (+25.46%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
23,707,076
Open
8.530
Bid (Size)
8.870 (1,900)
Ask (Size)
8.940 (600)
Prev. Close
7.030
Today's Range
8.500 - 9.600
52wk Range
3.809 - 7.469
Shares Outstanding
55,638,166
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
What's Going On With Vanda Pharmaceuticals Stock Wednesday?
↗
Today 15:07 EST
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares are trading higher Wednesday after the company announced it received FDA approval of NEREUS for the prevention of vomiting induced by motion.
Via
Benzinga
Here are the top movers in Wednesday's session.
↗
Today 15:00 EST
Via
Chartmill
Performance
YTD
+83.0%
+83.0%
1 Month
+75.7%
+75.7%
3 Month
+76.8%
+76.8%
6 Month
+88.5%
+88.5%
1 Year
+84.5%
+84.5%
More News
Read More
Top movers analysis in the middle of the day on 2025-12-31: top gainers and losers in today's session.
↗
Today 12:30 EST
Via
Chartmill
The market is filled with gapping stocks in Wednesday's session.
↗
Today 10:30 EST
Via
Chartmill
VNDA Stock On Track To Open At Three-Year High – FDA Clears First New Motion Sickness Drug In Decades
↗
Today 6:09 EST
Via
Stocktwits
Vanda’s FDA Moment: A High-Stakes Bet That Could Redefine The Stock
↗
December 29, 2025
Via
Stocktwits
The Christmas Party Is Still Ongoing In These Stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell
↗
December 26, 2025
Via
Stocktwits
Get insights into the top gainers and losers of Wednesday's pre-market session.
↗
Today 8:30 EST
Via
Chartmill
Nasdaq, S&P 500 Futures Edge Lower For Final Session Of 2025: Why NVDA, TSLA, VNDA Are On Traders' Radar Today
↗
Today 3:45 EST
Via
Stocktwits
Topics
Artificial Intelligence
ETFs
Economy
Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal
December 29, 2025
Via
MarketMinute
Topics
ETFs
Intellectual Property
Vanda Pharmaceuticals Says FDA Will Take More Time To Decide On Tradipitant Clinical Hold Re-Review
↗
November 28, 2025
Via
Stocktwits
Earnings Scheduled For October 29, 2025
↗
October 29, 2025
Via
Benzinga
This Smallcap Pharma Stock Is Gaining Retail Buzz Ahead Of A Key FDA Ruling
↗
December 26, 2025
Via
Stocktwits
Curious about the stocks that are showing activity after the closing bell on Thursday?
↗
December 04, 2025
Via
Chartmill
Should You Invest in This Under-the-Radar Weight Loss Stock?
↗
November 30, 2025
Via
The Motley Fool
Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat
↗
November 20, 2025
Via
Benzinga
Which stocks are moving on Tuesday?
↗
November 18, 2025
Via
Chartmill
Top movers in Tuesday's session
↗
November 18, 2025
Via
Chartmill
Side Effects From Wegovy? This Vanda Pharmaceuticals' Drug Halves Vomiting In Patients
↗
November 18, 2025
Via
Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
November 18, 2025
Via
Chartmill
This Docebo Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday
↗
November 05, 2025
Via
Benzinga
This Trex Company Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
↗
November 05, 2025
Via
Benzinga
VANDA PHARMACEUTICALS INC (NASDAQ:VNDA) Reports Q3 2025 Earnings Miss on Revenue, Beat on EPS
↗
October 29, 2025
Via
Chartmill
Topics
Earnings
Jim Cramer Calls Cameco A Good Company, Recommends Buying This Financial Stock
↗
October 27, 2025
Via
Benzinga
AnaptysBio Charts Path To Split Into Two Public Companies By 2026
↗
September 30, 2025
Via
Benzinga
Frequently Asked Questions
Is Vanda Pharmaceuticals Inc. - Common Stock publicly traded?
Yes, Vanda Pharmaceuticals Inc. - Common Stock is publicly traded.
What exchange does Vanda Pharmaceuticals Inc. - Common Stock trade on?
Vanda Pharmaceuticals Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Vanda Pharmaceuticals Inc. - Common Stock?
The ticker symbol for Vanda Pharmaceuticals Inc. - Common Stock is VNDA on the Nasdaq Stock Market
What is the current price of Vanda Pharmaceuticals Inc. - Common Stock?
The current price of Vanda Pharmaceuticals Inc. - Common Stock is 8.820
When was Vanda Pharmaceuticals Inc. - Common Stock last traded?
The last trade of Vanda Pharmaceuticals Inc. - Common Stock was at 12/31/25 04:00 PM ET
What is the market capitalization of Vanda Pharmaceuticals Inc. - Common Stock?
The market capitalization of Vanda Pharmaceuticals Inc. - Common Stock is 490.73M
How many shares of Vanda Pharmaceuticals Inc. - Common Stock are outstanding?
Vanda Pharmaceuticals Inc. - Common Stock has 491M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.